Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Seufferlein

Showing results (201-210 of 367) with videos related to

Pageof 37
Sort By:
Zeitschrift Fur Gastroenterologie|June 14, 2022
Thomas Seufferlein, Julia Mayerle, Susanne Blödt, et al.
European Journal of Cancer (Oxford, England : 1990)|May 27, 2014
Cytokine regulation by epidermal growth factor receptor inhibitors and epidermal growth factor receptor inhibitor associated skin toxicity in cancer patientsTanusree Paul, Christian Schumann, Stefan Rüdiger, et al.
United European Gastroenterology Journal|October 30, 2021
COVID-19 and digestive health: Implications for prevention, care and the use of COVID-19 vaccines in vulnerable patientsMarkus Peck-Radosavljevic, Patrizia Burra, Maria Buti Ferret, et al.
United European Gastroenterology Journal|August 18, 2025
Homologous Repair-Deficient Pancreatic Cancer: Refined Targeting of DNA Damage Response is an Effective Therapeutic StrategyAlica K Beutel, Christopher J Halbrook, Menar Ekizce, et al.
The Oncologist|February 19, 2016
Awareness, Understanding, and Adoption of Precision Medicine to Deliver Personalized Treatment for Patients With Cancer: A Multinational Survey Comparison of Physicians and PatientsFortunato Ciardiello, Richard Adams, Josep Tabernero, et al.
Cancers|March 25, 2022
Tumor Treating Fields Concomitant with Sorafenib in Advanced Hepatocellular Cancer: Results of the HEPANOVA Phase II StudyEleni Gkika, Anca-Ligia Grosu, Teresa Macarulla Mercade, et al.
Journal of Clinical Medicine|June 13, 2020
Adverse Drug Reactions in the Emergency Department: Is There a Role for Pharmacogenomic Profiles at Risk?-Results from the ADRED StudyKatja S Just, Harald Dormann, Marlen Schurig, et al.
Deutsches Arzteblatt International|May 9, 2018
Adverse Drug Reactions (ADR) and EmergenciesA Marlen Schurig, Miriam Böhme, Katja S Just, et al.
Nature Reviews. Disease Primers|May 19, 2016
Colorectal cancerErnst J Kuipers, William M Grady, David Lieberman, et al.
Journal for Immunotherapy of Cancer|January 17, 2025
Pancreatic cancer cell-intrinsic transglutaminase-2 promotes T cell suppression through microtubule-dependent secretion of immunosuppressive cytokinesAnton Lahusen, Nora Minhöfer, Kim-André Lohse, et al.
Pageof 37

Showing results (201-210 of 367) with videos related to

Sort By:
Pageof 37
Zeitschrift Fur Gastroenterologie|June 14, 2022
Thomas Seufferlein, Julia Mayerle, Susanne Blödt, et al.
European Journal of Cancer (Oxford, England : 1990)|May 27, 2014
Cytokine regulation by epidermal growth factor receptor inhibitors and epidermal growth factor receptor inhibitor associated skin toxicity in cancer patientsTanusree Paul, Christian Schumann, Stefan Rüdiger, et al.
United European Gastroenterology Journal|October 30, 2021
COVID-19 and digestive health: Implications for prevention, care and the use of COVID-19 vaccines in vulnerable patientsMarkus Peck-Radosavljevic, Patrizia Burra, Maria Buti Ferret, et al.
United European Gastroenterology Journal|August 18, 2025
Homologous Repair-Deficient Pancreatic Cancer: Refined Targeting of DNA Damage Response is an Effective Therapeutic StrategyAlica K Beutel, Christopher J Halbrook, Menar Ekizce, et al.
The Oncologist|February 19, 2016
Awareness, Understanding, and Adoption of Precision Medicine to Deliver Personalized Treatment for Patients With Cancer: A Multinational Survey Comparison of Physicians and PatientsFortunato Ciardiello, Richard Adams, Josep Tabernero, et al.
Cancers|March 25, 2022
Tumor Treating Fields Concomitant with Sorafenib in Advanced Hepatocellular Cancer: Results of the HEPANOVA Phase II StudyEleni Gkika, Anca-Ligia Grosu, Teresa Macarulla Mercade, et al.
Journal of Clinical Medicine|June 13, 2020
Adverse Drug Reactions in the Emergency Department: Is There a Role for Pharmacogenomic Profiles at Risk?-Results from the ADRED StudyKatja S Just, Harald Dormann, Marlen Schurig, et al.
Deutsches Arzteblatt International|May 9, 2018
Adverse Drug Reactions (ADR) and EmergenciesA Marlen Schurig, Miriam Böhme, Katja S Just, et al.
Nature Reviews. Disease Primers|May 19, 2016
Colorectal cancerErnst J Kuipers, William M Grady, David Lieberman, et al.
Journal for Immunotherapy of Cancer|January 17, 2025
Pancreatic cancer cell-intrinsic transglutaminase-2 promotes T cell suppression through microtubule-dependent secretion of immunosuppressive cytokinesAnton Lahusen, Nora Minhöfer, Kim-André Lohse, et al.
Pageof 37